Hindustan Bio Sciences Limited (BOM:532041)
India
· Delayed Price · Currency is INR 9.21
0.00 (0.00%)
At close: Apr 28, 2026
Hindustan Bio Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 0.11 | 0.35 | 0.1 | 0.09 | 0.17 | Upgrade
|
| Cash & Short-Term Investments | 0.16 | 0.11 | 0.35 | 0.1 | 0.09 | 0.17 | Upgrade
|
| Cash Growth | -90.91% | -68.86% | 266.98% | 4.50% | -45.33% | -91.51% | Upgrade
|
| Receivables | - | 4.42 | 4.42 | 4.54 | 1.35 | 6.17 | Upgrade
|
| Other Current Assets | - | 5.44 | 4.73 | 3.97 | 3.97 | 4.14 | Upgrade
|
| Total Current Assets | - | 9.97 | 9.5 | 8.6 | 5.41 | 10.48 | Upgrade
|
| Property, Plant & Equipment | - | 0.27 | 0.27 | 0.34 | 0.4 | 0.4 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.1 | 0.07 | 0.03 | 0.06 | 0.09 | Upgrade
|
| Other Long-Term Assets | - | 23.9 | 23.9 | 23.9 | 23.9 | 23.9 | Upgrade
|
| Total Assets | - | 34.24 | 33.74 | 32.87 | 29.76 | 34.86 | Upgrade
|
| Accounts Payable | - | 0.01 | 0.02 | 0.65 | 0.01 | 2.91 | Upgrade
|
| Accrued Expenses | - | 0.13 | 0.12 | 0.2 | 0.21 | 0.32 | Upgrade
|
| Short-Term Debt | - | - | - | 13.33 | 10.95 | 11.26 | Upgrade
|
| Total Current Liabilities | - | 0.14 | 0.14 | 14.18 | 11.17 | 14.49 | Upgrade
|
| Long-Term Debt | - | 25.05 | 25.56 | 11.22 | 10.72 | 7.33 | Upgrade
|
| Other Long-Term Liabilities | - | 0 | - | - | 0 | - | Upgrade
|
| Total Liabilities | - | 25.19 | 25.7 | 25.4 | 21.89 | 21.82 | Upgrade
|
| Common Stock | - | 20.5 | 20.5 | 20.5 | 102.51 | 102.51 | Upgrade
|
| Retained Earnings | - | -11.45 | -12.46 | -13.04 | -94.64 | -89.46 | Upgrade
|
| Comprehensive Income & Other | - | -0 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 8.6 | 9.05 | 8.04 | 7.47 | 7.87 | 13.05 | Upgrade
|
| Total Liabilities & Equity | - | 34.24 | 33.74 | 32.87 | 29.76 | 34.86 | Upgrade
|
| Total Debt | 26.16 | 25.05 | 25.56 | 24.55 | 21.67 | 18.59 | Upgrade
|
| Net Cash (Debt) | -26 | -24.94 | -25.21 | -24.46 | -21.57 | -18.42 | Upgrade
|
| Net Cash Per Share | -2.74 | -2.43 | -2.46 | -2.39 | -2.10 | -1.80 | Upgrade
|
| Filing Date Shares Outstanding | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | Upgrade
|
| Total Common Shares Outstanding | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | Upgrade
|
| Working Capital | - | 9.83 | 9.36 | -5.58 | -5.76 | -4.01 | Upgrade
|
| Book Value Per Share | 0.88 | 0.88 | 0.78 | 0.73 | 0.77 | 1.27 | Upgrade
|
| Tangible Book Value | 8.6 | 9.05 | 8.04 | 7.47 | 7.87 | 13.05 | Upgrade
|
| Tangible Book Value Per Share | 0.88 | 0.88 | 0.78 | 0.73 | 0.77 | 1.27 | Upgrade
|
| Machinery | - | 5.37 | 5.37 | 5.37 | 5.37 | 5.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.